BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34326011)

  • 1. Reply to "Maybe myopathic EMG but not myopathy" and to "Exclude differentials before attributing post-COVID fatigue to myopathy".
    Agergaard J; Leth S; Pedersen TH; Harbo T; Blicher JU; Karlsson P; Østergaard L; Andersen H; Tankisi H
    Clin Neurophysiol; 2021 Sep; 132(9):2326-2327. PubMed ID: 34326011
    [No Abstract]   [Full Text] [Related]  

  • 2. Exclude differentials before attributing post-COVID fatigue to myopathy.
    Finsterer J; Scorza FA
    Clin Neurophysiol; 2021 Sep; 132(9):2324-2325. PubMed ID: 34332866
    [No Abstract]   [Full Text] [Related]  

  • 3. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology.
    Hejbøl EK; Harbo T; Agergaard J; Madsen LB; Pedersen TH; Østergaard LJ; Andersen H; Schrøder HD; Tankisi H
    Eur J Neurol; 2022 Sep; 29(9):2832-2841. PubMed ID: 35661354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myopathic changes in patients with long-term fatigue after COVID-19.
    Agergaard J; Leth S; Pedersen TH; Harbo T; Blicher JU; Karlsson P; Østergaard L; Andersen H; Tankisi H
    Clin Neurophysiol; 2021 Aug; 132(8):1974-1981. PubMed ID: 34020890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical myopathic changes in COVID-19.
    Villa D; Ardolino G; Borellini L; Cogiamanian F; Vergari M; Savojardo V; Peyvandi F; Barbieri S
    Neurol Sci; 2021 Oct; 42(10):3973-3979. PubMed ID: 34304328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology.
    Agergaard J; Yamin Ali Khan B; Engell-Sørensen T; Schiøttz-Christensen B; Østergaard L; Hejbøl EK; Schrøder HD; Andersen H; Blicher JU; Holm Pedersen T; Harbo T; Tankisi H;
    Clin Neurophysiol; 2023 Apr; 148():65-75. PubMed ID: 36804609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reply to: Before attributing encephalomyelitis to SARS-CoV-2 vaccinations exclude differentials.
    Kania K; Ambrosius W; Tokarz Kupczyk E; Kozubski W
    Ann Clin Transl Neurol; 2021 Nov; 8(11):2224. PubMed ID: 34636495
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to "Post-COVID myopathy".
    Hejbøl EK; Harbo T; Agergaard J; Østergaard LJ; Andersen H; Schrøder HD; Tankisi H
    Eur J Neurol; 2022 Dec; 29(12):3752-3753. PubMed ID: 35971870
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to 'SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?'.
    Bagnato S; Boccagni C; Marino G; Prestandrea C; D'Agostino T; Rubino F
    Int J Infect Dis; 2020 Dec; 101():57. PubMed ID: 33002615
    [No Abstract]   [Full Text] [Related]  

  • 10. Maybe myopathic EMG but not myopathy.
    Cornblath DR
    Clin Neurophysiol; 2021 Sep; 132(9):2323. PubMed ID: 34332865
    [No Abstract]   [Full Text] [Related]  

  • 11. Elucidating the causes of post SARS-CoV-2 neuropathy / myopathy requires comprehensive investigations because of the broad spectrum of different etiologies.
    Finsterer J
    Int J Rheum Dis; 2023 May; 26(5):982-983. PubMed ID: 36374522
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to "Digging deeper on the neurophysiological assessment in COVID-19 patients" and "Myopathy in acute and long-term COVID-19".
    Hameed S; Khan S
    Clin Neurophysiol; 2022 Feb; 134():139-140. PubMed ID: 34991967
    [No Abstract]   [Full Text] [Related]  

  • 13. Before attributing encephalomyelitis to SARS-CoV-2 vaccinations thoroughly exclude differentials.
    Finsterer J
    Ann Clin Transl Neurol; 2021 Nov; 8(11):2222-2223. PubMed ID: 34783196
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased prevalence of mild myopathic changes in the post-COVID-19 duration.
    Gündüz A; Ser MH; Çalıkuşu FZ; Tanrıverdi U; Abbaszade H; Hakyemez S; Balkan ILİ; Karaali R; Kantarcı F; Uzun Adatepe N
    Neurol Res; 2024 Feb; 46(2):111-118. PubMed ID: 37729011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
    Finsterer J; Scorza FA
    Int J Infect Dis; 2020 Dec; 101():56. PubMed ID: 33002612
    [No Abstract]   [Full Text] [Related]  

  • 16. Critical illness myopathy after COVID-19.
    Bagnato S; Boccagni C; Marino G; Prestandrea C; D'Agostino T; Rubino F
    Int J Infect Dis; 2020 Oct; 99():276-278. PubMed ID: 32763444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature.
    Islam B; Ahmed M; Islam Z; Begum SM
    Skelet Muscle; 2021 Apr; 11(1):10. PubMed ID: 33883014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does SARS-CoV-2 truly cause infectious myopathy?
    Finsterer J; Scorza FA
    J Formos Med Assoc; 2021 Mar; 120(3):1032-1033. PubMed ID: 32917481
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to letter to the editor "Does SARS-CoV-2 truly cause infectious myopathy?".
    Chang KC
    J Formos Med Assoc; 2021 Mar; 120(3):1034-1035. PubMed ID: 32921536
    [No Abstract]   [Full Text] [Related]  

  • 20. [The Peripheral Neuropathy and Myopathy Associated with Severe Acute Respiratory Syndrome-Correlated New Coronavirus (SARS-Cov-2)].
    Takeshita Y; Kanda T
    Brain Nerve; 2020 Oct; 72(10):1045-1048. PubMed ID: 33051390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.